Another study identified S100A6 as a pancreatic cancer biomarker in cell lines, using laser capture microdissection, two-dimensional gel electrophoresis (2-DE), MS, and immunohistochemistry (Shekouh et al., 2003). Here, S100A6 is linked to pancreatic neoplasm.